Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Current Genomics|February 11, 2025
The Regulatory Landscape of Biobanks In Europe: From Accreditation to Intellectual PropertyAntonella Corradi, Giuseppina Bonizzi, Elham Sajjadi, et al.
Clinical Chemistry|April 30, 2016
Optimization and Standardization of Circulating MicroRNA Detection for Clinical Application: The miR-Test CaseMatteo Jacopo Marzi, Francesca Montani, Rose Mary Carletti, et al.
Virchows Archiv : an International Journal of Pathology|July 13, 2021
Basic principles of biobanking: from biological samples to precision medicine for patientsLaura Annaratone, Giuseppe De Palma, Giuseppina Bonizzi, et al.
Nature Communications|October 1, 2025
A histone-centric multi-omics study shows that increased H3K4 methylation sustains triple-negative breast cancer phenotypesRoberta Noberini, Giulia Robusti, Alessandro Vai, et al.
Plos Genetics|January 3, 2023
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC)Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, et al.
Cells|November 26, 2022
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for <i>PIK3CA</i> Testing in HR+/HER2- Breast CancerKonstantinos Venetis, Francesco Pepe, Elisabetta Munzone, et al.
Cancers|May 30, 2019
Profiling of Epigenetic Features in Clinical Samples Reveals Novel Widespread Changes in CancerRoberta Noberini, Camilla Restellini, Evelyn Oliva Savoia, et al.
Cells|July 27, 2022
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk ProfilesElham Sajjadi, Konstantinos Venetis, Marianna Noale, et al.
Journal of Clinical Medicine|October 6, 2020
Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care WorkersMargherita Bruni, Valentina Cecatiello, Angelica Diaz-Basabe, et al.
BMC Cancer|September 11, 2019
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)Giulia Marvaso, Delia Ciardo, Giulia Corrao, et al.
Pageof 4